Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Health Aff (Millwood) ; 42(7): 886-898, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-37315269

RESUMO

National health expenditures are projected to grow 5.4 percent, on average, over the course of 2022-31 and to account for roughly 20 percent of the economy by the end of that period. The insured share of the population is anticipated to exceed 92 percent through 2023, in part as a result of record-high Medicaid enrollment, and then decline toward 90 percent as coverage requirements related to the COVID-19 public health emergency expire. The prescription drug provisions of the Inflation Reduction Act of 2022 are anticipated to lower out-of-pocket spending for Medicare Part D enrollees beginning in 2024 and to result in savings to Medicare beginning in 2031.


Assuntos
COVID-19 , Medicare Part D , Idoso , Humanos , Estados Unidos , Gastos em Saúde , Saúde Pública , Cobertura do Seguro , Medicaid
2.
Health Aff (Millwood) ; 41(4): 474-486, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-35344446

RESUMO

Although considerable uncertainty remains, the COVID-19 pandemic and public health emergency are expected to continue to influence the near-term outlook for national health spending and enrollment. National health spending growth is expected to have decelerated from 9.7 percent in 2020 to 4.2 percent in 2021 as federal supplemental funding was expected to decline substantially relative to 2020. Through 2024 health care use is expected to normalize after the declines observed in 2020, health insurance enrollments are assumed to evolve toward their prepandemic distributions, and the remaining federal supplemental funding is expected to wane. Economic growth is expected to outpace health spending growth for much of this period, leading the projected health share of gross domestic product (GDP) to decline from 19.7 percent in 2020 to just over 18 percent over the course of 2022-24. For 2025-30, factors that typically drive changes in health spending and enrollment, such as economic, demographic, and health-specific factors, are again expected to primarily influence trends in the health sector. By 2030 the health spending share of GDP is projected to reach 19.6 percent.


Assuntos
COVID-19 , Gastos em Saúde , Previsões , Produto Interno Bruto , Humanos , Seguro Saúde , Pandemias , Estados Unidos/epidemiologia
3.
Health Aff (Millwood) ; 39(4): 704-714, 2020 04.
Artigo em Inglês | MEDLINE | ID: mdl-32207998

RESUMO

National health expenditures are projected to grow at an average annual rate of 5.4 percent for 2019-28 and to represent 19.7 percent of gross domestic product by the end of the period. Price growth for medical goods and services is projected to accelerate, averaging 2.4 percent per year for 2019-28, which partly reflects faster expected growth in health-sector wages. Among all major payers, Medicare is expected to experience the fastest spending growth (7.6 percent per year), largely as a result of having the highest projected enrollment growth. The insured share of the population is expected to fall from 90.6 percent in 2018 to 89.4 percent by 2028.


Assuntos
Gastos em Saúde , Medicare , Idoso , Previsões , Produto Interno Bruto , Humanos , Seguro Saúde , Estados Unidos
4.
Health Aff (Millwood) ; 38(3): 491-501, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30785832

RESUMO

National health expenditures are projected to grow at an average annual rate of 5.5 percent for 2018-27 and represent 19.4 percent of gross domestic product in 2027. Following a ten-year period largely influenced by the Great Recession and major health reform, national health spending growth during 2018-27 is expected to be driven primarily by long-observed demographic and economic factors fundamental to the health sector. Prices for health care goods and services are projected to grow 2.5 percent per year, on average, for 2018-27-faster than the average price growth experienced over the last decade-and to account for nearly half of projected personal health care spending growth. Among the major payers, average annual spending growth in Medicare (7.4 percent) is expected to exceed that in Medicaid (5.5 percent) and private health insurance (4.8 percent) over the projection period, mostly as a result of comparatively higher projected enrollment growth. The insured share of the population is expected to remain stable at around 90 percent throughout the period, as net gains in health coverage from all sources are projected to keep pace with population growth.


Assuntos
Demografia/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Demografia/tendências , Previsões , Custos de Cuidados de Saúde/estatística & dados numéricos , Custos de Cuidados de Saúde/tendências , Gastos em Saúde/tendências , Humanos , Medicaid/estatística & dados numéricos , Medicaid/tendências , Medicare/estatística & dados numéricos , Medicare/tendências , Crescimento Demográfico , Estados Unidos
5.
Health Aff (Millwood) ; 37(3): 482-492, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29443634

RESUMO

Under current law, national health spending is projected to grow 5.5 percent annually on average in 2017-26 and to represent 19.7 percent of the economy in 2026. Projected national health spending and enrollment growth over the next decade is largely driven by fundamental economic and demographic factors: changes in projected income growth, increases in prices for medical goods and services, and enrollment shifts from private health insurance to Medicare that are related to the aging of the population. The recent enactment of tax legislation that eliminated the individual mandate is expected to result in only a small reduction to insurance coverage trends.


Assuntos
Previsões , Produto Interno Bruto/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Cobertura do Seguro/tendências , Medicare/economia , Incerteza , Comércio , Desenvolvimento Econômico/tendências , Produto Interno Bruto/tendências , Gastos em Saúde/tendências , Humanos , Patient Protection and Affordable Care Act , Estados Unidos
6.
Health Serv Res ; 53(1): 326-340, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28074495

RESUMO

OBJECTIVE: To compare Medicaid fee-for-service (FFS) inpatient hospital payments to expected Medicare payments. DATA SOURCES: Medicaid and Medicare claims data, Medicare's MS-DRG grouper and inpatient prospective payment system pricer (IPPS pricer). STUDY DESIGN: Medicaid FFS inpatient hospital claims were run through Medicare's MS-DRG grouper and IPPS pricer to compare Medicaid's actual payment against what Medicare would have paid for the same claim. PRINCIPAL FINDINGS: Average inpatient hospital claim payments for Medicaid were 68.8 percent of what Medicare would have paid in fiscal year 2010, and 69.8 percent in fiscal year 2011. Including Medicaid disproportionate share hospital (DSH), graduate medical education (GME), and supplemental payments reduces a substantial proportion of the gap between Medicaid and Medicare payments. CONCLUSIONS: Medicaid payments relative to expected Medicare payments tend to be lower and vary by state Medicaid program, length of stay, and whether payments made outside of the Medicaid claims process are included.


Assuntos
Planos de Pagamento por Serviço Prestado/economia , Hospitalização/economia , Pacientes Internados/estatística & dados numéricos , Medicaid/economia , Medicare/economia , Pesquisa sobre Serviços de Saúde , Humanos , Revisão da Utilização de Seguros , Tempo de Internação , Estados Unidos
7.
Health Aff (Millwood) ; 36(3): 553-563, 2017 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-28202501

RESUMO

Under current law, national health expenditures are projected to grow at an average annual rate of 5.6 percent for 2016-25 and represent 19.9 percent of gross domestic product by 2025. For 2016, national health expenditure growth is anticipated to have slowed 1.1 percentage points to 4.8 percent, as a result of slower Medicaid and prescription drug spending growth. For the rest of the projection period, faster projected growth in medical prices is partly offset by slower projected growth in the use and intensity of medical goods and services, relative to that observed in 2014-16 associated with the Affordable Care Act coverage expansions. The insured share of the population is projected to increase from 90.9 percent in 2015 to 91.5 percent by 2025.


Assuntos
Envelhecimento , Comércio/economia , Gastos em Saúde/estatística & dados numéricos , Gastos em Saúde/tendências , Cobertura do Seguro/tendências , Previsões , Produto Interno Bruto/tendências , Humanos , Seguro Saúde/economia , Seguro Saúde/tendências , Medicaid , Medicare , Medicamentos sob Prescrição , Estados Unidos
8.
Health Aff (Millwood) ; 35(8): 1522-31, 2016 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-27411572

RESUMO

Health spending growth in the United States for 2015-25 is projected to average 5.8 percent-1.3 percentage points faster than growth in the gross domestic product-and to represent 20.1 percent of the total economy by 2025. As the initial impacts associated with the Affordable Care Act's coverage expansions fade, growth in health spending is expected to be influenced by changes in economic growth, faster growth in medical prices, and population aging. Projected national health spending growth, though faster than observed in the recent history, is slower than in the two decades before the recent Great Recession, in part because of trends such as increasing cost sharing in private health insurance plans and various Medicare payment update provisions. In addition, the share of total health expenditures paid for by federal, state, and local governments is projected to increase to 47 percent by 2025.


Assuntos
Centers for Medicare and Medicaid Services, U.S./tendências , Gastos em Saúde/tendências , Cobertura do Seguro/tendências , Patient Protection and Affordable Care Act/organização & administração , Envelhecimento , Desenvolvimento Econômico/tendências , Recessão Econômica/tendências , Feminino , Previsões , Humanos , Masculino , Medição de Risco , Estados Unidos
9.
Health Aff (Millwood) ; 34(8): 1407-17, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26220668

RESUMO

Health spending growth in the United States is projected to average 5.8 percent for 2014-24, reflecting the Affordable Care Act's coverage expansions, faster economic growth, and population aging. Recent historically low growth rates in the use of medical goods and services, as well as medical prices, are expected to gradually increase. However, in part because of the impact of continued cost-sharing increases that are anticipated among health plans, the acceleration of these growth rates is expected to be modest. The health share of US gross domestic product is projected to rise from 17.4 percent in 2013 to 19.6 percent in 2024.


Assuntos
Custos de Medicamentos/tendências , Gastos em Saúde/tendências , Cobertura do Seguro/tendências , Seguro Saúde/tendências , Medicamentos sob Prescrição/economia , Previsões , Produto Interno Bruto/tendências , Hospitais/estatística & dados numéricos , Hospitais/tendências , Humanos , Seguro Saúde/economia , Medicaid/economia , Medicaid/tendências , Medicare/economia , Medicare/tendências , Modelos Econométricos , Patient Protection and Affordable Care Act/tendências , Médicos/estatística & dados numéricos , Médicos/tendências , Medicamentos sob Prescrição/uso terapêutico , Estados Unidos
10.
Health Aff (Millwood) ; 34(1): 111-6, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25561651

RESUMO

Out-of-pocket health care spending in the United States totaled $306.2 billion in 2010 and represented 11.8 percent of total national health expenditures, according to the Centers for Medicare and Medicaid Services' National Health Expenditure Accounts. Spending by people with employer-sponsored health insurance and those covered by Medicare accounted for over 80 percent of total out-of-pocket spending. People without comprehensive medical coverage accounted for less than 8 percent of all out-of-pocket expenditures in 2010. Between 2007 and 2010 per person out-of-pocket spending grew most rapidly for people primarily covered by employer-sponsored insurance and declined for people primarily covered by Medicare and those without coverage.


Assuntos
Gastos em Saúde/tendências , Cobertura do Seguro/economia , Cobertura do Seguro/tendências , Custos e Análise de Custo/tendências , Previsões , Planos de Assistência de Saúde para Empregados/economia , Planos de Assistência de Saúde para Empregados/tendências , Medicaid/economia , Medicaid/tendências , Medicare/economia , Medicare/tendências , Estados Unidos
11.
Health Aff (Millwood) ; 33(10): 1841-50, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25187525

RESUMO

In 2013 health spending growth is expected to have remained slow, at 3.6 percent, as a result of the sluggish economic recovery, the effects of sequestration, and continued increases in private health insurance cost-sharing requirements. The combined effects of the Affordable Care Act's coverage expansions, faster economic growth, and population aging are expected to fuel health spending growth this year and thereafter (5.6 percent in 2014 and 6.0 percent per year for 2015-23). However, the average rate of increase through 2023 is projected to be slower than the 7.2 percent average growth experienced during 1990-2008. Because health spending is projected to grow 1.1 percentage points faster than the average economic growth during 2013-23, the health share of the gross domestic product is expected to rise from 17.2 percent in 2012 to 19.3 percent in 2023.


Assuntos
Gastos em Saúde/tendências , Cobertura do Seguro/tendências , Custos de Medicamentos/tendências , Previsões , Produto Interno Bruto/tendências , Hospitais/estatística & dados numéricos , Hospitais/tendências , Humanos , Seguro Saúde/economia , Seguro Saúde/tendências , Medicaid/economia , Medicaid/tendências , Medicare/economia , Medicare/tendências , Modelos Econométricos , Patient Protection and Affordable Care Act/tendências , Médicos/estatística & dados numéricos , Médicos/tendências , Medicamentos sob Prescrição/economia , Medicamentos sob Prescrição/uso terapêutico , Estados Unidos
12.
Health Aff (Millwood) ; 32(10): 1820-31, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24047555

RESUMO

Health spending growth through 2013 is expected to remain slow because of the sluggish economic recovery, continued increases in cost-sharing requirements for the privately insured, and slow growth for public programs. These factors lead to projected growth rates of near 4 percent through 2013. However, improving economic conditions, combined with the coverage expansions in the Affordable Care Act and the aging of the population, drive faster projected growth in health spending in 2014 and beyond. Expected growth for 2014 is 6.1 percent, with an average projected growth of 6.2 percent per year thereafter. Over the 2012-22 period, national health spending is projected to grow at an average annual rate of 5.8 percent. By 2022 health spending financed by federal, state, and local governments is projected to account for 49 percent of national health spending and to reach a total of $2.4 trillion.


Assuntos
Recessão Econômica , Gastos em Saúde/tendências , Cobertura do Seguro/tendências , Seguro Saúde , Humanos , Estados Unidos
13.
Health Aff (Millwood) ; 31(7): 1600-12, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22692089

RESUMO

For 2011-13, US health spending is projected to grow at 4.0 percent, on average--slightly above the historically low growth rate of 3.8 percent in 2009. Preliminary data suggest that growth in consumers' use of health services remained slow in 2011, and this pattern is expected to continue this year and next. In 2014, health spending growth is expected to accelerate to 7.4 percent as the major coverage expansions from the Affordable Care Act begin. For 2011 through 2021, national health spending is projected to grow at an average rate of 5.7 percent annually, which would be 0.9 percentage point faster than the expected annual increase in the gross domestic product during this period. By 2021, federal, state, and local government health care spending is projected to be nearly 50 percent of national health expenditures, up from 46 percent in 2011, with federal spending accounting for about two-thirds of the total government share. Rising government spending on health care is expected to be driven by faster growth in Medicare enrollment, expanded Medicaid coverage, and the introduction of premium and cost-sharing subsidies for health insurance exchange plans.


Assuntos
Desenvolvimento Econômico/tendências , Gastos em Saúde/tendências , Cobertura do Seguro/tendências , Seguro Saúde/tendências , Desenvolvimento Econômico/estatística & dados numéricos , Economia Hospitalar/tendências , Financiamento Pessoal/economia , Financiamento Pessoal/tendências , Previsões , Hospitais/estatística & dados numéricos , Hospitais/tendências , Humanos , Cobertura do Seguro/economia , Cobertura do Seguro/estatística & dados numéricos , Seguro Saúde/economia , Seguro Saúde/estatística & dados numéricos , Medicaid/economia , Medicaid/tendências , Medicare/economia , Medicare/tendências , Modelos Econométricos , Patient Protection and Affordable Care Act , Médicos/economia , Médicos/tendências , Medicamentos sob Prescrição/economia , Medicamentos sob Prescrição/uso terapêutico , Estados Unidos
14.
Health Aff (Millwood) ; 30(8): 1594-605, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21798885

RESUMO

In 2010, US health spending is estimated to have grown at a historic low of 3.9 percent, due in part to the effects of the recently ended recession. In 2014, national health spending growth is expected to reach 8.3 percent when major coverage expansions from the Affordable Care Act of 2010 begin. The expanded Medicaid and private insurance coverage are expected to increase demand for health care significantly, particularly for prescription drugs and physician and clinical services. Robust growth in Medicare enrollment, expanded Medicaid coverage, and premium and cost-sharing subsidies for exchange plans are projected to increase the federal government share of health spending from 27 percent in 2009 to 31 percent by 2020. This article provides perspective on how the nation's health care dollar will be spent over the coming decade as the health sector moves quickly toward its new paradigm of expanded insurance coverage.


Assuntos
Gastos em Saúde/tendências , Patient Protection and Affordable Care Act , Recessão Econômica , Previsões , Estados Unidos
15.
Health Aff (Millwood) ; 29(10): 1933-41, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20829295

RESUMO

This paper presents updated national health spending projections for 2009-2019 that take into account recent comprehensive health reform legislation and other relevant changes in law and regulations. Relative to our February 2010 projections under prior law, average annual growth in national health spending over the projection period is estimated to be 0.2 percentage point higher than our previous estimate. The health care share of gross domestic product (GDP) is expected to be 0.3 percentage point higher in 2019. Within these net overall impacts are larger differences for trends in spending and spending growth by payer, attributable to reform's many major changes to health care coverage and financing.


Assuntos
Reforma dos Serviços de Saúde/economia , Gastos em Saúde/tendências , Previsões , Produto Interno Bruto , Estados Unidos
16.
Health Aff (Millwood) ; 29(3): 522-9, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20133357

RESUMO

The economic recession and rising unemployment-plus changing demographics and baby boomers aging into Medicare-are among the factors expected to influence health spending during 2009-2019. In 2009 the health share of gross domestic product (GDP) is expected to have increased 1.1 percentage points to 17.3 percent-the largest single-year increase since 1960. Average public spending growth rates for hospital, physician and clinical services, and prescription drugs are expected to exceed private spending growth in the first four years of the projections. As a result, public spending is projected to account for more than half of all U.S. health care spending by 2012.


Assuntos
Recessão Econômica , Custos de Cuidados de Saúde/tendências , Gastos em Saúde/tendências , Previsões , Custos de Cuidados de Saúde/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Humanos , Estados Unidos
17.
Health Aff (Millwood) ; 28(2): w346-57, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19240055

RESUMO

During the projection period (2008-2018), average annual growth in national health spending is projected to be 6.2 percent-2.1 percentage points faster than average annual growth in gross domestic product (GDP). The health share of GDP is anticipated to rise rapidly from 16.2 percent in 2007 to 17.6 percent in 2009, largely as a result of the recession, and then climb to 20.3 percent by 2018. Public payers are expected to become the largest source of funding for health care in 2016 and are projected to pay for more than half of all national health spending in 2018.


Assuntos
Recessão Econômica/estatística & dados numéricos , Previsões , Gastos em Saúde/tendências , Medicare/tendências , Recessão Econômica/tendências , Gastos em Saúde/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde , Humanos , Medicare/economia , Setor Público , Incerteza , Estados Unidos
18.
Health Aff (Millwood) ; 26(2): w242-53, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17314105

RESUMO

Growth in national health spending is projected to slow slightly from 6.9 percent in 2005 to 6.8 percent in 2006, marking the fourth consecutive year of a slowing trend. The health share of gross domestic product (GDP) is expected to hold steady in 2006 before resuming its historical upward trend, reaching 19.6 percent of GDP by 2016. Prescription drug spending growth is expected to accelerate to 6.5 percent in 2006. Medicare prescription drug coverage has dramatically changed the distribution of drug spending among payers, but the net effect on aggregate spending is anticipated to be small.


Assuntos
Reforma dos Serviços de Saúde/economia , Gastos em Saúde/tendências , Centers for Medicare and Medicaid Services, U.S. , Redução de Custos , Financiamento Pessoal/tendências , Previsões , Gastos em Saúde/estatística & dados numéricos , Humanos , Inflação , Medicare/tendências , Honorários por Prescrição de Medicamentos/tendências , Qualidade da Assistência à Saúde , Planos Governamentais de Saúde , Estados Unidos
19.
Health Care Financ Rev ; 29(2): 1-4, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18435218

RESUMO

The following overview introduces a series of articles that focuses on multifactor productivity (MFP) growth in health care. This edition of the Health Care Financing Review begins with a theoretical discussion of the Medicare Economic Index (MEI) and the conceptual reasons for the MFP adjustment incorporated into the Medicare physician fee schedule (MPFS). The issue then moves on to an exploratory data-driven analysis of MFP growth in physicians' offices, and an evaluation of that exploration. Finally, the edition concludes with an empirically-based analysis of MFP growth in the hospital sector, as well as a study related to Medicare physician payment that looks at the individual contributors to recent growth in relative value units (RVUs).


Assuntos
Atenção à Saúde/organização & administração , Eficiência Organizacional/tendências , Honorários e Preços/legislação & jurisprudência , Humanos , Medicare , Escalas de Valor Relativo , Estados Unidos
20.
Health Care Financ Rev ; 25(3): 1-4, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15229992

RESUMO

The following commentary unites a collection of articles primarily concerned with prescription drug issues in Medicaid. It also features highlights from a piece outlining Australia's pharmaceutical delivery system. Specifically, in this issue, you will find comprehensive analyses of drug expenditure trends, issues regarding access to pharmaceuticals in Medicaid, and an evaluation of ongoing generic drug cost-containment programs.


Assuntos
Custos de Medicamentos/tendências , Seguro de Serviços Farmacêuticos , Medicaid , Controle de Custos , Acessibilidade aos Serviços de Saúde , Humanos , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...